IRIS
VETRO, CALOGERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.458
EU - Europa 847
AS - Asia 708
AF - Africa 144
SA - Sud America 85
Continente sconosciuto - Info sul continente non disponibili 39
OC - Oceania 4
Totale 3.285
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.416
RU - Federazione Russa 378
SG - Singapore 348
IT - Italia 229
CN - Cina 189
CI - Costa d'Avorio 93
BR - Brasile 65
IE - Irlanda 62
VN - Vietnam 53
KR - Corea 42
FR - Francia 29
GB - Regno Unito 23
SE - Svezia 23
CA - Canada 21
NG - Nigeria 19
UA - Ucraina 19
FI - Finlandia 18
IN - India 15
SN - Senegal 15
DE - Germania 14
MX - Messico 12
HK - Hong Kong 11
ES - Italia 10
AR - Argentina 9
BD - Bangladesh 9
CZ - Repubblica Ceca 8
ZA - Sudafrica 7
IQ - Iraq 6
NL - Olanda 6
PL - Polonia 6
TR - Turchia 6
JP - Giappone 5
AU - Australia 4
BE - Belgio 4
BJ - Benin 4
BO - Bolivia 4
LT - Lituania 4
PH - Filippine 4
RO - Romania 4
EG - Egitto 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
RS - Serbia 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.247
Salva come PNG Salva come JPEG
Città #
Singapore 233
Dallas 230
Moscow 189
Santa Clara 173
Houston 167
San Jose 103
Abidjan 93
Ashburn 85
Chicago 79
Hefei 66
Dublin 60
Chandler 57
Los Angeles 43
Seoul 42
Council Bluffs 41
Beijing 35
Civitanova Marche 35
Boardman 28
New York 26
Ho Chi Minh City 24
Rome 24
Lauterbourg 23
Milan 18
Dakar 15
Florence 14
Buffalo 13
Catania 13
Cambridge 12
Lawrence 12
Jacksonville 11
Palermo 11
Hong Kong 10
Lagos 10
Abuja 9
Hanoi 9
Helsinki 9
São Paulo 9
Andover 8
Stockholm 8
Chennai 7
London 7
Munich 7
Boston 6
Falls Church 6
Lappeenranta 6
Orem 6
Warsaw 6
Atlanta 5
Johannesburg 5
Manchester 5
Phoenix 5
Piazzola Sul Brenta 5
San Francisco 5
Seattle 5
Tokyo 5
Toronto 5
Washington 5
Wilmington 5
Amsterdam 4
Belo Horizonte 4
Brooklyn 4
Brussels 4
Cotonou 4
Denver 4
Dong Ket 4
Mascalucia 4
Montreal 4
Nanjing 4
Poplar 4
Querétaro 4
Brno 3
Cairo 3
Charlotte 3
Des Moines 3
Frankfurt am Main 3
Lamezia Terme 3
Melbourne 3
Miami 3
Mumbai 3
Olomouc 3
Paris 3
Roseto degli Abruzzi 3
Turku 3
Acalanes Ridge 2
Albany 2
Ankara 2
Asunción 2
Buenos Aires 2
Campinas 2
Cernusco sul Naviglio 2
Haiphong 2
Indpls 2
Jeddah 2
Jiaxing 2
José C. Paz 2
Karachi 2
Kochi 2
Las Vegas 2
Madrid 2
Manassas 2
Totale 2.274
Salva come PNG Salva come JPEG
Nome #
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy 303
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 167
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 163
A case of high-risk AML in a patient with advanced systemic mastocytosis 160
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 145
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 140
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases 137
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 131
Emerging Therapeutic Approaches for Anemia in Myelofibrosis 126
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 126
Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field 126
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 123
Abnormal F-18 fluorodeoxyglucose uptake of the lung in immunocompromised lymphoma patients in complete remission: Report of two cases and revision of literature 123
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 119
Advances in understanding regulatory myeloid cells 118
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? 114
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 114
Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up 114
Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters 113
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes 111
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease 109
VEXAS-like syndrome: a potential new entity? 102
Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association 99
Pegylated liposomal doxorubicin in salvage chemotherapy for multiple myeloma patients 73
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 70
Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model 14
Does the Timing of Response Impact the Outcome of Relapsed/Refractory Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents? A Proof of Concept from a Monocentric Observational Study 10
Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with Venetoclax 10
Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance Database 9
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape 7
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders 6
Real-World Outcomes in FLT3-ITD Mutated Acute Myeloid Leukemia: Impact of NPM1 Mutations and Allogeneic Transplantation in a Retrospective Unicentric Cohort 3
Totale 3.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.941
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202293 0 0 0 0 14 7 14 3 10 14 5 26
2022/2023218 14 20 10 14 11 23 7 43 53 3 12 8
2023/2024236 10 39 10 21 5 51 18 19 3 8 36 16
2024/2025629 7 121 27 59 121 73 21 19 35 39 56 51
2025/20261.741 90 180 223 105 221 452 126 30 105 114 74 21
2026/2027148 38 101 9 0 0 0 0 0 0 0 0 0
Totale 3.285